Conference Reports for NATAP

EASL - The International Liver Congress 2014 49th Annual Meeting of the European Association for the Study of the Liver London, United Kingdom  April 9-13 Back

RESULTS FROM THE PHASE 2 PEARL-I STUDY: INTERFERON-FREE REGIMENS OF ABT-450/r + ABT-267 WITH OR WITHOUT RIBAVIRIN IN PATIENTS WITH HCV GENOTYPE 4 INFECTION       Reported by Jules Levin EASL 2014 April 9-13 London, UK   Christophe Hezode, Patrick Marcellin, Stanislas Pol, Tarek Hassanein, Katarzyna Fleischer-Stepniewska, Tolga Baykal, Tianli Wang, Sandra S. Lovell, Tami Pilot-Matias, Regis A. Vilchez